The Tri-Institutional MD-PhD Program (Tri-I) is a joint undertaking between Weill Cornell Medicine, The Rockefeller University, and Memorial Sloan Kettering Cancer Center. Trainees complete their MD degree at Weill Cornell Medical College, and PhD training at one of the three participating graduate schools: Weill Cornell Graduate School of Medical Sciences; the David Rockefeller Graduate Program in Bioscience; or the Louis V. Gerstner Jr. Graduate School of Biomedical Sciences. Tri-I guides students through a rigorous course of study that offers flexibility and unfettered access to experienced mentors in leading laboratories. An integrated curriculum reinforces the students’ identities as clinician-scientists; equally well-prepared to work in the laboratory and at the bedside, Tri-I graduates bridge the gap between clinical medicine and laboratory research. 

Learn more about the Tri-Institutional MD-PhD Program by watching the short video below.

Rohan Roy, a fourth year student in the Tri-I MD-PhD program, has been awarded an NIH F30 research grant. This award will support Mr. Roy's work in the Hudspeth Lab at The Rockefeller University, where he is currently working on his PhD.
The work of Dr. Darren Orcbach, MD, PhD and Dr. Peter Weinstock, MD, PhD, both members of the Tri-I graduating class of 1998, made possible the first successful fetal intracranial intervention earlier this month. Denver Coleman was diagnosed with life-threatening Vein of Galen Malformation (VOGM) and was treated in utero by Dr. Orbach, the first time such a procedure was done.